These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10532096)

  • 41. Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.
    Boccadoro M; Palumbo A; Bringhen S; Merletti F; Ciccone G; Richiardi L; Rus C; Bertola A; Giaccone L; Omedè P; Musto P
    Haematologica; 2002 Aug; 87(8):846-50. PubMed ID: 12161361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies.
    Williams CB; Day SD; Reed MD; Copelan EA; Bechtel T; Leather HL; Wingard JR; Abbott BL; Abhyankar S; McGuirk JP
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):614-23. PubMed ID: 15319773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma.
    Ritchie DS; Seymour JF; Grigg AP; Roberts AW; Hoyt R; Thompson S; Szer J; Prince HM
    Ann Hematol; 2007 Feb; 86(2):101-5. PubMed ID: 17089127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral blood leukocyte count as an index of defense status in the leukopenic host.
    Cawley S; Findon G; Miller TE
    J Lab Clin Med; 1988 Jul; 112(1):52-7. PubMed ID: 3392457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
    Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S
    Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery.
    Ottosson S; Magnusson K; Hultborn R
    Anticancer Res; 1999; 19(5C):4429-34. PubMed ID: 10650787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells.
    Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
    Clin Exp Med; 2006 Dec; 6(4):177-90. PubMed ID: 17191110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selenate- and selenomethionine-induced leukopenia in ICR female mice.
    Hogan GR
    J Toxicol Environ Health A; 1998 Jan; 53(2):113-9. PubMed ID: 9444315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Betaleukin (human recombinant interleukin-1beta) for the prevention and correction of toxic leukopenia in chemotherapy of malignant neoplasms].
    Gershanovich ML; Filatova LV; Ketlinskiĭ SA; Simbirtsev AS
    Vopr Onkol; 1998; 44(2):181-6. PubMed ID: 9615823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of combined administration of cytembena and cyclophosphamide on the blood count and morphology of nucleoli in peripheral-blood lymphocytes in patients with malignant tumors.
    Matĕjková E
    Neoplasma; 1975; 22(1):45-54. PubMed ID: 1173938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Kinetic patterns of changes in the number of peripheral blood leukocytes in lung cancer patients after treatment with cyclophosphane combined with cystaphos].
    Disvetova VV; Levitin EI; Trakhtenberg AKh; Batinov IN
    Izv Akad Nauk SSSR Biol; 1977; (3):351-6. PubMed ID: 886069
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of recombinant Ganoderma lucidum immunoregulatory protein on cyclophosphamide-induced leukopenia in mice.
    Zhou H; Sun F; Li H; Zhang S; Liu Z; Pei J; Liang C
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):426-33. PubMed ID: 23656432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Leukocyte count and granulocyte function of children under lithium carbonate therapy treated with cytostatic drugs. A pilot study].
    Burdach SE; Rister M; Evers KG; Froehlich W
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):38-42. PubMed ID: 6700601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ka-mi-kae-kyuk-tang oriental herbal cocktail attenuates cyclophosphamide-induced leukopenia side effects in mouse.
    Seo I; Kim SH; Lee JE; Jeong SJ; Kim YC; Ahn KS; Lu J; Kim SH
    Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):682-90. PubMed ID: 21395405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The etiocholanolone test for prediction of the leukopenic effect of cytoxic drugs.
    Karjalainen J; Wasastjerna C
    Scand J Haematol; 1973; 11(5):337-41. PubMed ID: 4778496
    [No Abstract]   [Full Text] [Related]  

  • 57. Measurement of apoptotic cells in peripheral blood.
    Carbonari M; Cibati M; Fiorilli M
    Cytometry; 1995 Sep; 22(3):161-7. PubMed ID: 8556946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [On quantitative changes in the leukocytes and thrombocytes after chemotherapy in patients with malignant tumors of the ovaries].
    Livshits MA
    Vopr Onkol; 1966; 12(8):42-6. PubMed ID: 4972210
    [No Abstract]   [Full Text] [Related]  

  • 59. [On clinical use of high single doses of sarcolysine and exdoxan (cyclophosphan)].
    Garin AM; Astrakhan VI; Bychkov MB; Larionov LF; Perevodchikova NI
    Vopr Onkol; 1965; 11(10):3-9. PubMed ID: 5333877
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of re-infusions of isolated irradiated auto-blood for the correction of hematopoietic disorders].
    Gaĭseniuk LA
    Med Radiol (Mosk); 1987 Nov; 32(11):15-8. PubMed ID: 3683116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.